Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Reexamination Certificate
2007-04-10
2007-04-10
Parkin, Jeffrey S. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
C424S186100, C424S184100, C424S230100, C435S002000, C435S007100, C435S007210, C530S326000, C530S327000
Reexamination Certificate
active
10434982
ABSTRACT:
The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.
REFERENCES:
Zugel et al. Termination of peripheral tolerance to a T cell epitope by heterolitic antigen analogues. The Journal of Immunology, 1998, 1706-1709.
Chen et al. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. The Journal of Immunology, 2000, 948-955.
Miltenyi Biotec's CMV pp65-recombinant protein human cytomegalovirus, 2006.
Chen, Ji-Li et al., “Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL”, The Journal of Immunology, 2000, 165:948-955.
Zugel, Ulrich et al., “Termination of Peripheral Tolerance to a T Cell Epitope by Heteroclitic Antigen Analogues”, The Journal of Immunology, 1998, 161:1705-1709.
Genzyme Corporation
Le Emily M.
Parkin Jeffrey S.
LandOfFree
Therapeutic anti-cytomegalovirus compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic anti-cytomegalovirus compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic anti-cytomegalovirus compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3721725